Marker | Values | Coef | SE | HR (95% CI) | P-value |
---|---|---|---|---|---|
Age at diagnosis | Continuous (yrs) | 0.021 | 0.023 | 1.02 (0.98–1.07) | 0.36 |
Gender | Male | Â | Â | 1 (ref) | Â |
 | Female | 0.109 | 0.272 | 1.11 (0.65–1.90) | 0.69 |
TNM stagea | I | Â | Â | 1 (ref) | Â |
 | II | 0.569 | 0.638 | 1.77 (0.51–6.17) | 0.37 |
 | III | 1.207 | 0.685 | 3.34 (0.87–12.79) | 0.08 |
 | IV | 1.884 | 0.915 | 6.58 (1.09–39.57) | 0.04 |
Fuhrman grade | G1 | Â | Â | 1 (ref) | Â |
 | G2 | -0.112 | 0.426 | 0.89 (0.39–2.06) | 0.79 |
 | G3 | -0.047 | 0.437 | 0.95 (0.41–2.25) | 0.92 |
 | G4 | 0.955 | 0.462 | 2.60 (1.05–6.43) | 0.04 |
Tumor size | Continuous (mm) | -0.003 | 0.005 | 1.00 (0.99–1.01) | 0.59 |
NEFH-ii | U | Â | Â | 1 (ref) | Â |
 | M | -0.002 | 0.298 | 1.00 (0.56–1.79) | 0.99 |
NEURL-ii | U | Â | Â | 1 (ref) | Â |
 | M | 0.475 | 0.280 | 1.61 (0.93–2.78) | 0.09 |
LAD1-ii | U | Â | Â | 1 (ref) | Â |
 | M | 0.738 | 0.258 | 2.07 (1.25–3.43) | 0.01 |
GREM1-ii | U | Â | Â | 1 (ref) | Â |
 | M | -0.456 | 0.284 | 0.64 (0.36–1.11) | 0.11 |
GATA5 | U | Â | Â | 1 (ref) | Â |
 | M | 0.351 | 0.283 | 1.43 (0.82–2.49) | 0.20 |